These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 10213959)

  • 21. The effect of soluble complement receptor type 1 on hyperacute xenograft rejection.
    Pruitt SK; Baldwin WM; Marsh HC; Lin SS; Yeh CG; Bollinger RR
    Transplantation; 1991 Nov; 52(5):868-73. PubMed ID: 1949173
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Neutrophil adhesion and complement inhibition prolongs survival of cardiac xenografts in discordant species.
    Zehr KJ; Herskowitz A; Lee PC; Kumar P; Gillinov AM; Baumgartner WA
    Transplantation; 1994 Mar; 57(6):900-6. PubMed ID: 8154039
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [The effect of nafamstat mesilate (FUT175) on hyperacute rejection in discordant cardiac xenograft (guinea pig to rat): preliminary report].
    Fukushima N; Shirakura R; Nakata S; Ito T; Miyagawa S; Matsumiya G; Matsuda H
    Nihon Geka Gakkai Zasshi; 1992 Feb; 93(2):218. PubMed ID: 1552896
    [No Abstract]   [Full Text] [Related]  

  • 24. Effect of immunomodulatory artificial blood exchange (IABX) on guinea pig-to-rat heart xenografts.
    Wada S; Murakami H; Sueda T; Kajihara H; Matsuura Y
    Hiroshima J Med Sci; 1994 Dec; 43(4):153-61. PubMed ID: 7883581
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hyperacute rejection in a discordant (pig to baboon) cardiac xenograft model.
    Lexer G; Cooper DK; Rose AG; Wicomb WN; Rees J; Keraan M; Du Toit E
    J Heart Transplant; 1986; 5(6):411-8. PubMed ID: 3302173
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The mechanism of discordant xenograft rejection.
    Miyagawa S; Hirose H; Shirakura R; Nakata S; Naka Y; Kitagawa S; Nakano S; Matsumoto M; Seya T; Kitamura H
    Transplant Proc; 1989 Feb; 21(1 Pt 1):520-1. PubMed ID: 2650190
    [No Abstract]   [Full Text] [Related]  

  • 27. Electroporation-mediated interleukin-10 overexpression in skeletal muscle reduces acute rejection in rat cardiac allografts.
    Tavakoli R; Gazdhar A; Pierog J; Bogdanova A; Gugger M; Pringle IA; Gill DR; Hyde SC; Genoni M; Schmid RA
    J Gene Med; 2006 Feb; 8(2):242-8. PubMed ID: 16389627
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Vaccinia virus complement control protein inhibits hyperacute xenorejection in a guinea pig-to-rat heterotopic cervical cardiac xenograft model by blocking both xenoantibody binding and complement pathway activation.
    Anderson JB; Smith SA; van Wijk R; Chien S; Kotwal GJ
    Transpl Immunol; 2003; 11(2):129-35. PubMed ID: 12799195
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of anticomplement agent K76 COOH on hamster-to-rat and guinea pig-to-rat heart xenotransplantation.
    Tanaka M; Murase N; Ye Q; Miyazaki W; Nomoto M; Miyazawa H; Manez R; Toyama Y; Demetris AJ; Todo S; Starzl TE
    Transplantation; 1996 Sep; 62(5):681-8. PubMed ID: 8830837
    [TBL] [Abstract][Full Text] [Related]  

  • 30. C1-Inh and heparan sulfate can prevent discordant rejection.
    Di Stefano R; Frosini F; Scavuzzo M; Ambrogi M; Fagiolini A; Ferrari M; Pelosi G; Mosca F
    Transplant Proc; 1994 Jun; 26(3):1172-3. PubMed ID: 8029876
    [No Abstract]   [Full Text] [Related]  

  • 31. Effects of FC43 emulsion against hyperacute rejection in rodent discordant xenotransplantation.
    Wada S; Kajihara H; Murakami H; Sueda T; Matsuura Y
    J Heart Lung Transplant; 1995; 14(5):968-72. PubMed ID: 8800735
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Complement inactivated, preformed antibodies do not play a pivotal role in delayed rejection of a guinea pig-to-rat cardiac xenograft.
    Grimm H; Mages P; Lindemann G; Potthoff M; Bohnet U; Linder R; Korom S
    Transplant Proc; 2001; 33(1-2):753-6. PubMed ID: 11267054
    [No Abstract]   [Full Text] [Related]  

  • 33. [Attempt at preventing hyperacute xenogenic rejection by isotopic suppression of IgM in the recipient].
    Pitre J; Kahan A; Fontaliran P; Houssin D; Weill B
    Ann Chir; 1996; 50(7):524-31. PubMed ID: 9035421
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Attenuation of acute xenograft rejection by short-term treatment with LF15-0195 and monoclonal antibody against CD45RB in a rat-to-mouse cardiac transplantation model.
    Wang H; Hosiawa KA; Garcia B; Shum JB; Dutartre P; Kelvin DJ; Zhong R
    Transplantation; 2003 May; 75(9):1475-81. PubMed ID: 12792500
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prolonged cardiac allograft survival in presensitized rats after a high activity Yunnan-cobra venom factor therapy.
    Li R; Chen G; Guo H; Wang DW; Xie L; Wang SS; Wang WY; Xiong YL; Chen S
    Transplant Proc; 2006 Dec; 38(10):3263-5. PubMed ID: 17175243
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Administration of GAS914 in an orthotopic pig-to-baboon heart transplantation model.
    Brandl U; Michel S; Erhardt M; Brenner P; Bittmann I; Rössle M; Baschnegger H; Bauer A; Hammer C; Schmoeckel M; Reichart B
    Xenotransplantation; 2005 Mar; 12(2):134-41. PubMed ID: 15693844
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of repetitive doses of soluble human complement receptor type 1 on survival of discordant cardiac xenografts.
    Xia W; Fearon DT; Kirkman RL
    Transplant Proc; 1993 Feb; 25(1 Pt 1):410-1. PubMed ID: 8438357
    [No Abstract]   [Full Text] [Related]  

  • 38. Rat strain differences in complement activity correlate with hyperacute rejection of guinea pig cardiac xenografts.
    Brauer RB; Baldwin WM; Pruitt SK; Sanfilippo F
    Transplant Proc; 1993 Oct; 25(5):2848-9. PubMed ID: 8212257
    [No Abstract]   [Full Text] [Related]  

  • 39. A novel recombinant fibrinogenase of Agkistrodon acutus venom protects against hyperacute rejection via degradation of complements.
    Lin X; Qi JZ; Chen MH; Qiu BT; Huang ZH; Qiu PX; Chen JS; Yan GM
    Biochem Pharmacol; 2013 Mar; 85(6):772-9. PubMed ID: 23178656
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The graft content of hyaluronan is increased during xenograft rejection.
    Lorant T; Tufveson G; Johnsson C
    Xenotransplantation; 2004 May; 11(3):269-75. PubMed ID: 15099207
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.